Skip to main content
. 2016 Nov 16;3(4):314–322. doi: 10.1200/JGO.2016.006072

Fig 1.

Fig 1

Reclassification of tumors reported to be clinically positive for human epidermal growth factor receptor 2 (cHER2+) using immunohistochemistry (IHC)/fluorescent in situ hybridization (FISH) into HER2-enriched (HER2E) and luminal subtypes. Equiv, equivocal.